Some 68,265,200 people were likely to have been resident in the UK in the middle of last year, up 662,400 from 67,602,800 12 ...
According to USFDA, as with all rapid antigen tests, which generally have lower sensitivity than molecular tests, there is a ...
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
SASSA has responded to recent media claims that 17 million applications were submitted in September 2024 for the SRD grant.